You are viewing the site in preview mode

Skip to main content

Table 2 Immune-related adverse events

From: Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

irAEa Any Grade Grade 1–2 Grade 3
n = 104 (%) n = 104 (%) n = 104 (%)
Any irAE 29 (28) 25 (24) 4 (4)
 Hypothyroidism 9 (9) 9 (9) 0 (0)
 Skin reaction 5 (5) 5 (5) 0 (0)
 Hepatitis 4 (4) 1 (1) 3 (3)
 Diarrhea 3 (3) 3 (3) 0 (0)
 Pneumonitis 3 (3) 3 (3) 0 (0)
 Other 5 (5) 4 (4) 1 (1)
  1. airAE Immune-related adverse event. No grade 4 and 5 events were observed
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us